PRO-DEX INC (PDEX)
US74265M2052 - Common Stock
Taking everything into account, PDEX scores 6 out of 10 in our fundamental rating. PDEX was compared to 192 industry peers in the Health Care Equipment & Supplies industry. PDEX gets an excellent profitability rating and is at the same time showing great financial health properties. PDEX has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
PDEX had positive earnings in the past year.
PDEX had a positive operating cash flow in the past year.
Each year in the past 5 years PDEX has been profitable.
In multiple years PDEX reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 9.72%, PDEX belongs to the top of the industry, outperforming 93.23% of the companies in the same industry.
The Return On Equity of PDEX (15.73%) is better than 91.67% of its industry peers.
With an excellent Return On Invested Capital value of 11.79%, PDEX belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PDEX is above the industry average of 8.50%.
The last Return On Invested Capital (11.79%) for PDEX is above the 3 year average (10.53%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.72% | ||
| ROE | 15.73% | ||
| ROIC | 11.79% |
ROA(3y)12.75%
ROA(5y)14.83%
ROE(3y)23.69%
ROE(5y)25.51%
ROIC(3y)10.53%
ROIC(5y)14.2%
1.3 Margins
PDEX's Profit Margin of 10.36% is amongst the best of the industry. PDEX outperforms 84.38% of its industry peers.
PDEX's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 13.03%, PDEX belongs to the best of the industry, outperforming 83.85% of the companies in the same industry.
In the last couple of years the Operating Margin of PDEX has declined.
PDEX's Gross Margin of 28.25% is on the low side compared to the rest of the industry. PDEX is outperformed by 74.48% of its industry peers.
PDEX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.03% | ||
| PM (TTM) | 10.36% | ||
| GM | 28.25% |
OM growth 3Y-14.89%
OM growth 5Y-3.75%
PM growth 3Y-4.37%
PM growth 5Y16.3%
GM growth 3Y-9.82%
GM growth 5Y-4.78%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PDEX is creating some value.
The number of shares outstanding for PDEX has been reduced compared to 1 year ago.
The number of shares outstanding for PDEX has been reduced compared to 5 years ago.
PDEX has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.62 indicates that PDEX is not in any danger for bankruptcy at the moment.
PDEX's Altman-Z score of 4.62 is fine compared to the rest of the industry. PDEX outperforms 75.52% of its industry peers.
The Debt to FCF ratio of PDEX is 3.99, which is a good value as it means it would take PDEX, 3.99 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PDEX (3.99) is better than 85.94% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that PDEX is not too dependend on debt financing.
The Debt to Equity ratio of PDEX (0.26) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 3.99 | ||
| Altman-Z | 4.62 |
ROIC/WACC1.23
WACC9.56%
2.3 Liquidity
PDEX has a Current Ratio of 3.66. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
PDEX has a Current ratio of 3.66. This is comparable to the rest of the industry: PDEX outperforms 55.73% of its industry peers.
A Quick Ratio of 2.16 indicates that PDEX has no problem at all paying its short term obligations.
The Quick ratio of PDEX (2.16) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.66 | ||
| Quick Ratio | 2.16 |
3. Growth
3.1 Past
PDEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.18%.
The Earnings Per Share has been growing slightly by 1.60% on average over the past years.
PDEX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.01%.
PDEX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.45% yearly.
EPS 1Y (TTM)-27.18%
EPS 3Y-4.63%
EPS 5Y1.6%
EPS growth Q2Q-41.67%
Revenue 1Y (TTM)9.01%
Revenue growth 3Y9.79%
Revenue growth 5Y15.45%
Revenue growth Q2Q11.6%
3.2 Future
PDEX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.66% yearly.
Based on estimates for the next years, PDEX will show a small growth in Revenue. The Revenue will grow by 4.28% on average per year.
EPS Next Y-46.27%
EPS Next 2Y3.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2Y4.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 24.81, which indicates a rather expensive current valuation of PDEX.
81.25% of the companies in the same industry are more expensive than PDEX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of PDEX to the average of the S&P500 Index (24.55), we can say PDEX is valued inline with the index average.
With a Price/Forward Earnings ratio of 13.22, PDEX is valued correctly.
94.79% of the companies in the same industry are more expensive than PDEX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.92. PDEX is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.81 | ||
| Fwd PE | 13.22 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PDEX indicates a rather cheap valuation: PDEX is cheaper than 94.27% of the companies listed in the same industry.
PDEX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PDEX is cheaper than 89.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.61 | ||
| EV/EBITDA | 8.74 |
4.3 Compensation for Growth
The decent profitability rating of PDEX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)15.5
EPS Next 2Y3.66%
EPS Next 3YN/A
5. Dividend
5.1 Amount
PDEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PRO-DEX INC
NASDAQ:PDEX (5/1/2024, 3:30:00 PM)
18.61
+0.11 (+0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap65.32M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.81 | ||
| Fwd PE | 13.22 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)15.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.72% | ||
| ROE | 15.73% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 13.03% | ||
| PM (TTM) | 10.36% | ||
| GM | 28.25% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.94
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.66 | ||
| Quick Ratio | 2.16 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-27.18%
EPS 3Y-4.63%
EPS 5Y
EPS growth Q2Q
EPS Next Y-46.27%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.01%
Revenue growth 3Y9.79%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y